InvestorsHub Logo
Followers 6
Posts 119
Boards Moderated 0
Alias Born 01/04/2012

Re: None

Monday, 06/25/2012 8:03:57 PM

Monday, June 25, 2012 8:03:57 PM

Post# of 22684
I find it interesting that Adam Fueurenstein waited until today to report that the AdComm minutes were less than fully supportive of Lorcaserin getting approved. As I recall, Adam live blogged while he watched the entire AdComm meeting firsthand and reported at that time that he was impressed with ARNA's response to the FDA and said he felt Lorcaserin would be approved. If he heard the whole presentation firsthand and felt Lorcaserin would be approved, why would he change his mind based on the minutes? He's a real piece of work.